GenBioPro Sues FDA To Keep Generic Mifepristone Available; Supreme Court Delays Its Decision

 
• By Brenda Sandburg

GenBioPro asks Maryland district court to prevent FDA from taking enforcement actions against it if Supreme Court allows stay of approval of mifepristone. Justice Samuel Alito extends deadline to respond until midnight Friday.

Courthouse
GenBioPro asks court to prevent FDA from taking enforcement action against its generic mifepristone • Source: Shutterstock

More from US FDA

More from Agency Leadership